3,3',4,5'-tetrahydroxystilbene has been researched along with Colonic Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chiou, YS; Ho, CT; Lan, YM; Lee, PS; Lin, Q; Nagabhushanam, K; Pan, MH | 1 |
Elzey, BD; Guo, XX; Kershaw, JC; Kim, KH | 1 |
Darzynkiewicz, Z; Halicka, HD; Hsieh, TC; Lucas, J; Wu, JM | 1 |
Kundu, JK; Lee, JS; Na, HK; Surh, YJ; Youn, J | 1 |
Abrantes, M; Duarte, N; Ferreira, MJ; Lage, H | 1 |
Doh, HJ; Hong, S; Jeong, S; Jung, Y; Kim, DD; Park, M; Yum, S | 1 |
6 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Colonic Neoplasms
Article | Year |
---|---|
Piceatannol Prevents Colon Cancer Progression via Dual-Targeting to M2-Polarized Tumor-Associated Macrophages and the TGF-β1 Positive Feedback Signaling Pathway.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Feedback; Humans; Mice; Signal Transduction; Stilbenes; Transforming Growth Factor beta1; Tumor Microenvironment; Tumor-Associated Macrophages | 2022 |
Piceatannol, a Dietary Polyphenol, Alleviates Adipose Tissue Loss in Pre-Clinical Model of Cancer-Associated Cachexia via Lipolysis Inhibition.
Topics: Adipose Tissue; Animals; Cachexia; Colonic Neoplasms; Culture Media, Conditioned; Cytokines; Lipolysis; Mice; Neoplasms; Polyphenols; Stilbenes; Weight Loss | 2022 |
Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling.
Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; E1A-Associated p300 Protein; Female; G1 Phase Cell Cycle Checkpoints; Histone Deacetylases; Humans; NF-kappa B; Programmed Cell Death 1 Receptor; Resveratrol; Signal Transduction; Stilbenes; Treatment Outcome; Triple Negative Breast Neoplasms; Up-Regulation | 2018 |
Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colonic Neoplasms; Dextran Sulfate; DNA-Binding Proteins; Down-Regulation; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; I-kappa B Kinase; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Resveratrol; STAT3 Transcription Factor; Stilbenes; Time Factors | 2009 |
Phenolic compounds as selective antineoplasic agents against multidrug-resistant human cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Multiple; Euphorbia; Flavanones; Humans; Lignans; Magnoliopsida; Myristicaceae; Neoplasms; Pancreatic Neoplasms; Phenols; Phytotherapy; Plant Extracts; Stilbenes; Stomach Neoplasms | 2010 |
Piceatannol, a hydroxystilbene natural product, stabilizes HIF-1α protein by inhibiting HIF prolyl hydroxylase.
Topics: Ascorbic Acid; Cell Line, Tumor; Colitis; Colonic Neoplasms; HEK293 Cells; Heme Oxygenase-1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Procollagen-Proline Dioxygenase; Stilbenes; Vascular Endothelial Growth Factor A | 2013 |